TITAN PHARMACEUTICALS INC — Director's Dealing 2017

Sep 20, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP)
CIK: 0000910267
Period of Report: 2017-09-15

Reporting Person: Kumar Rajinder (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-15	Option to Purchase Common Stock	$1.50	A	10000	Acquired	2027-09-15	Common Stock (10000)	Direct

Footnotes

F1: The option vests in 12 equal monthly installments commencing as of September 1, 2017.